|
⚲
|
| Keyboard |
| Milligan David V
✚
|
|
|---|---|
| CIK # | 0001222252 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001222252] | |
| 4 | [0001222252] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Milligan David V | |
| Madrigal Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to buy) · derivative
|
2022-06-16 | Grant | 9,470 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to buy) · derivative
|
2021-06-17 | Grant | 12,489 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to buy) · derivative
|
2020-06-17 | Grant | 6,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2019-06-27 | Grant | 10,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2018-11-21 | Sell | 20,000 | $112.54 | 2,250,800 |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2018-11-19 | Sell | 10,000 | $131.60 | 1,316,000 |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2018-11-14 | Option exercise | 10,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2018-11-14 | Option exercise | 10,000 | $16.46 | 164,600 |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2018-09-18 | Option exercise | 20,000 | $9.45 | 189,000 |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2018-09-18 | Option exercise | 20,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2018-06-19 | Grant | 10,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2017-06-29 | Grant | 10,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2016-07-22 | Grant | 20,000 | $0.00 |